| Name | Mobocertinib |
|---|
| Description | Mobocertinib is a potent epidermal growth factor receptor (EGFR) inhibitor and an antineoplastic agent, extracted from patent WO2019222093A1, compound A[1][2]. |
|---|---|
| Related Catalog | |
| References |
[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). |
| Molecular Formula | C32H39N7O4 |
|---|---|
| Molecular Weight | 585.70 |